Cargando…
Clinical potential of gene mutations in lung cancer
Lung cancer is the most common cancer type worldwide and the leading cause of cancer related deaths in the United States. The majority of newly diagnosed patients present with late stage metastatic lung cancer that is inoperable and resistant to therapies. High-throughput genomic technologies have m...
Autores principales: | Carper, Miranda B., Claudio, Pier Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4658345/ https://www.ncbi.nlm.nih.gov/pubmed/26603430 http://dx.doi.org/10.1186/s40169-015-0074-1 |
Ejemplares similares
-
RGS16, a novel p53 and pRb cross-talk candidate inhibits migration and invasion of pancreatic cancer cells
por: Carper, Miranda B., et al.
Publicado: (2014) -
Targeting a Newly Established Spontaneous Feline Fibrosarcoma Cell Line by Gene Transfer
por: Nande, Rounak, et al.
Publicado: (2012) -
The feasibility of gene therapy in the treatment of head and neck cancer
por: Vattemi, Emanuela, et al.
Publicado: (2009) -
The Evolution of Ketosis: Potential Impact on Clinical Conditions
por: Dilliraj, Latha Nagamani, et al.
Publicado: (2022) -
Epidermal growth factor receptor (EGFR) mutations in
lung cancer: preclinical and clinical data
por: Jorge, S.E.D.C., et al.
Publicado: (2014)